Empirical performance of the calibrated self-controlled cohort analysis within temporal pattern discovery: lessons for developing a risk identification and analysis system
- PMID: 24166228
- DOI: 10.1007/s40264-013-0095-x
Empirical performance of the calibrated self-controlled cohort analysis within temporal pattern discovery: lessons for developing a risk identification and analysis system
Abstract
Background: Observational healthcare data offer the potential to identify adverse drug reactions that may be missed by spontaneous reporting. The self-controlled cohort analysis within the Temporal Pattern Discovery framework compares the observed-to-expected ratio of medical outcomes during post-exposure surveillance periods with those during a set of distinct pre-exposure control periods in the same patients. It utilizes an external control group to account for systematic differences between the different time periods, thus combining within- and between-patient confounder adjustment in a single measure.
Objectives: To evaluate the performance of the calibrated self-controlled cohort analysis within Temporal Pattern Discovery as a tool for risk identification in observational healthcare data.
Research design: Different implementations of the calibrated self-controlled cohort analysis were applied to 399 drug-outcome pairs (165 positive and 234 negative test cases across 4 health outcomes of interest) in 5 real observational databases (four with administrative claims and one with electronic health records).
Measures: Performance was evaluated on real data through sensitivity/specificity, the area under receiver operator characteristics curve (AUC), and bias.
Results: The calibrated self-controlled cohort analysis achieved good predictive accuracy across the outcomes and databases under study. The optimal design based on this reference set uses a 360 days surveillance period and a single control period 180 days prior to new prescriptions. It achieved an average AUC of 0.75 and AUC >0.70 in all but one scenario. A design with three separate control periods performed better for the electronic health records database and for acute renal failure across all data sets. The estimates for negative test cases were generally unbiased, but a minor negative bias of up to 0.2 on the RR-scale was observed with the configurations using multiple control periods, for acute liver injury and upper gastrointestinal bleeding.
Conclusions: The calibrated self-controlled cohort analysis within Temporal Pattern Discovery shows promise as a tool for risk identification; it performs well at discriminating positive from negative test cases. The optimal parameter configuration may vary with the data set and medical outcome of interest.
Similar articles
-
A comparison of the empirical performance of methods for a risk identification system.Drug Saf. 2013 Oct;36 Suppl 1:S143-58. doi: 10.1007/s40264-013-0108-9. Drug Saf. 2013. PMID: 24166231
-
Empirical performance of a self-controlled cohort method: lessons for developing a risk identification and analysis system.Drug Saf. 2013 Oct;36 Suppl 1:S95-106. doi: 10.1007/s40264-013-0101-3. Drug Saf. 2013. PMID: 24166227
-
Replication of the OMOP experiment in Europe: evaluating methods for risk identification in electronic health record databases.Drug Saf. 2013 Oct;36 Suppl 1:S159-69. doi: 10.1007/s40264-013-0109-8. Drug Saf. 2013. PMID: 24166232
-
Desideratum for evidence based epidemiology.Drug Saf. 2013 Oct;36 Suppl 1:S5-14. doi: 10.1007/s40264-013-0102-2. Drug Saf. 2013. PMID: 24166219 Review.
-
Trigger Tool-Based Automated Adverse Event Detection in Electronic Health Records: Systematic Review.J Med Internet Res. 2018 May 30;20(5):e198. doi: 10.2196/jmir.9901. J Med Internet Res. 2018. PMID: 29848467 Free PMC article.
Cited by
-
Variation in choice of study design: findings from the Epidemiology Design Decision Inventory and Evaluation (EDDIE) survey.Drug Saf. 2013 Oct;36 Suppl 1:S15-25. doi: 10.1007/s40264-013-0103-1. Drug Saf. 2013. PMID: 24166220
-
Adverse Drug Reaction Discovery from Electronic Health Records with Deep Neural Networks.Proc ACM Conf Health Inference Learn (2020). 2020 Apr;2020:30-39. doi: 10.1145/3368555.3384459. Proc ACM Conf Health Inference Learn (2020). 2020. PMID: 33283213 Free PMC article.
-
Structured assessment for prospective identification of safety signals in electronic medical records: evaluation in the health improvement network.Drug Saf. 2015 Jan;38(1):87-100. doi: 10.1007/s40264-014-0251-y. Drug Saf. 2015. PMID: 25539877 Free PMC article.
-
A comparison of the empirical performance of methods for a risk identification system.Drug Saf. 2013 Oct;36 Suppl 1:S143-58. doi: 10.1007/s40264-013-0108-9. Drug Saf. 2013. PMID: 24166231
-
The State of Use and Utility of Negative Controls in Pharmacoepidemiologic Studies.Am J Epidemiol. 2024 Feb 5;193(3):426-453. doi: 10.1093/aje/kwad201. Am J Epidemiol. 2024. PMID: 37851862 Free PMC article. Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical